Sign In
Buy NURO
$4.58
+0 (+0%)
At Close: Jul 30, 2025
The Daily Biotech Pulse: AstraZeneca Faces Setback In Ovarian Cancer Study, Mallinckrodt To Explore COVID-19 Treatment, Imara IPO
12:00am, Thursday, 12'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on March 11)
Bicycle Therapeutics...
NeuroMetrix Provides Quell® Technology Commercial Strategy and Pipeline Update
03:00pm, Wednesday, 11'th Mar 2020
NeuroMetrix, Inc. (NURO) today provided an update on its Quell technology commercial strategy and pipeline. An estimated 100 million US adults have chronic pain. People with chronic pain may also ha
The Daily Biotech Pulse: NY State Endorses Mallinckrodt's Opioid Settlement, Kamada To Work On COVID-19 Treatment
12:03pm, Wednesday, 11'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 10) Arcutis Biotherapeutics Inc (NASDAQ: ARQT ) Aytu
NeuroMetrix Offers Update On Quell Technology Commercial Strategy, Pipeline
12:00am, Wednesday, 11'th Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit 52-week highs March 9.) Arcutis Biotherapeutics Inc (NASDAQ: ARQT ) Enzo Bi
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks that hit 52-week highs March 9.)
Arcutis...
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks that hit hit 52-week highs March 5.) Arcus Biosciences Inc (NYSE: RCUS ) Arcturus Th
101 Biggest Movers From Yesterday
09:28am, Friday, 06'th Mar 2020
Gainers
Cohen & Company Inc. (NYSE: COHN) shares climbed 27.8% to close at $5.11 on Thursday. The Israeli company posted a Q4 profit of $0.56 per share, versus a year-ago...
NeuroMetrix Reports Clinical Studies Recently Published on DPNCheck®
05:14pm, Thursday, 05'th Mar 2020
WOBURN, Mass., March 05, 2020 -- NeuroMetrix, Inc. (Nasdaq: NURO) today reported the recent publication of three additional DPNCheck clinical studies. DPNCheck is a.
GWRE, BHP among premarket losers
02:20pm, Thursday, 05'th Mar 2020
NeuroMetrix (NASDAQ:NURO) -18%.Guidewire Software (NYSE:GWRE) -14% on Q2 earnings.VBI Vaccines (NASDAQ:VBIV) -11% on FY earnings.Cellect Biotechnology (NASDAQ:APOP) -12%.Eros International (NYSE:E
NeuroMetrix Press Release Highlights 3 Added DPNCheck Clinical Studies
12:00am, Thursday, 05'th Mar 2020NeuroMetrix 8-K Shows Settlement With FTC For Probe Initiated In 2017 Related To Co.'s Representations Of Quell Product; Will Pay $4M
12:00am, Wednesday, 04'th Mar 2020The Daily Biotech Pulse: GenMark Diagnostics Ships COVID-19 Test Kits, Karyopharm To Offer Shares, And More
12:51pm, Tuesday, 03'rd Mar 2020
Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week highs on March 2) Forty Seven Inc (NASDAQ: FTSV )( announced a deal
BPS: Partisipasi warga Kota Malang ikuti sensus "online" masih rendah
12:06pm, Monday, 02'nd Mar 2020
Badan Pusat Statistik (BPS) Kota Malang menyebutkan tingkat partisipasi warga Kota Malang, Jawa Timur, pada Sensus Penduduk 2020 secara ...
The Daily Biotech Pulse: Sangamo In Genome-Editing Therapy Deal With Biogen, FDA Nod For Biohaven, Passage Bio IPO
12:28pm, Friday, 28'th Feb 2020
Here's a roundup of top developments in the biotech space over the last 24 hours.
Scaling The Peaks
(Biotech Stocks Hitting 52-week highs on Feb. 27)
Global Cord Blood Corp (...
